Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Bioweapon ricin - scientists solve mystery through revolutionary new technology

02.12.2011
A key protein that controls how the deadly plant poison and bioweapon ricin kills, has finally been identified by researchers at the Institute of Molecular Biotechnology in Vienna, Austria. The discovery was made using a revolutionary technology that combines stem cell biology and modern screening methods, and reported today (Friday 2 December 2011) in the scientific journal Cell Stem Cell.

Shocking news spread in August this year. Al Quaida, a terror organization, was reported to be producing bombs containing the poison ricin to attack shopping centers, airports, or train stations. Since the First World War, ricin has had a gruesome reputation as a bioweapon. It is one of the deadliest plant based poisons in the world. Even a tiny amount can kill a person within two to three days after getting into the bloodstream. And it comes from the humble castor oil bean, available in many health food shops or online.

How the poison works

Castor oil is a powerful laxative, used medicinally for centuries, but the raw beans also contain small amounts of the poison ricin. So far no antidote is available. But now Ulrich Elling, a scientist on the research team led by Prof Josef Penninger at the Institute for Molecular Biotechnology (IMBA) of the Austrian Academy of Sciences in Vienna, has identified a protein molecule called Gpr107. This protein in the targeted cells is essential for the deadly effect of ricin. In other words, cells which lack Gpr107 are immune to the poison.

Ulrich Elling is optimistic, saying "Our research suggests that a specific antidote could now be developed by making a small molecule to block the Gpr107 protein."

New technology allows screening of the entire mammal genome

The researchers at IMBA were able to find in just a few weeks what others have been trying to find for decades. Their rapid success was made possible by a pioneering new method of genetic research developed largely by Ulrich Elling and Josef Penninger. With this new method, an entire mammal genome can be screened for mutations within a reasonable time frame.

Until now, screening methods for mice, rats and other mammals have focused on finding one single mutation. This was done using a technique called RNA interference or by breeding a suitable ‘knock-out mouse’ to study the effect of removing a single gene. But RNA interference doesn't always work, and breeding a knock-out mouse takes years and considerable effort.

That's why Josef Penninger sees this powerful technology as a revolution in biomedicine. "We've now succeeded in combining the genetics of yeast, which has a single chromosome set that allows instant gene mutation, with stem cell biology”, he says. “For decades researchers have been looking for a system in mammals which would allow scientists to reconstruct millions of gene mutations simultaneously. We have solved the puzzle and even broke a paradigm in biology – we managed to make stable mouse stem cells with a single set of chromosomes and developed novel tools to use such stem cells to rapidly check virtually all genes at the same time for a specific function.”

This new technology helped Ulrich Elling in unraveling the toxic effect of ricin. He tested the poison in thousands of different mutations of mouse stem cells, and discovered that 49 different genetic mutations were present in one single protein, Gpr107. Obviously, a mutation in this protein saved the cells.

Combination with stem cell research reveals broad range of applications

The incredible potential in this discovery becomes even clearer in the light of stem cells' ability to transform into any cell in the human body. Josef Penninger is excited. "The possible uses of this discovery are endless. They range from fundamental issues, like which genes are necessary for the proper function of a heart muscle cell, to concrete applications as we have done in the case of ricin toxicity."

Penninger's team is already working on its next projects, including studies on how tumor cells acquire resistance to chemotherapy, a key issue in the development of cancer, and how nerve cells can regenerate, to offer hope in cases of paraplegia.

Notes to news editors:

The scientific study "Forward and Reverse Genetics through Derivation of Haploid Mouse Embryonic Stem Cells" appears in Cell Stem Cell on Friday 2 December 2011.

The study was conducted by an international consortium from Austria, Canada, Germany and the USA under the leadership of IMBA. Special thanks go to William Stanford from the Sprott Centre for Stem Cell Research at the Ottawa Hospital Research Institute, Harald von Melchner and Frank Schnütgen from the University of Cologne, Joseph Ecker from San Diego, and Johannes Zuber and Alex Stark from the IMP in Vienna.

The Institute for Molecular Biotechnology (IMBA) is a research institute of the Austrian Academy of Sciences (Österreichische Akademie der Wissenschaften).

Screening: Systematic examination for defined criteria.

RNA interference: A mechanism in cells through which genes can be switched off.

Knock-out mouse: A mouse in which one or more genes have been deactivated. This genetic alteration is often apparent in the mouse's behavior or appearance. These mice are helpful as models for studying human diseases.

Contact and interview requests:

Evelyn Devuyst, Communications IMBA - Institute of Molecular Biotechnology
Tel. +43 1 797 30 - 3626
evelyn.devuyst@imba.oeaw.ac.at

Evelyn Devuyst | idw
Further information:
http://www.imba.oeaw.ac.at

More articles from Life Sciences:

nachricht Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery
20.01.2017 | GSI Helmholtzzentrum für Schwerionenforschung GmbH

nachricht Seeking structure with metagenome sequences
20.01.2017 | DOE/Joint Genome Institute

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

Helmholtz International Fellow Award for Sarah Amalia Teichmann

20.01.2017 | Awards Funding

An innovative high-performance material: biofibers made from green lacewing silk

20.01.2017 | Materials Sciences

Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery

20.01.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>